Tizanidin zehirlenmesi (iki olgu nedeniyle)
Tizanidin santral etkili bir kas gevşeticidir. İlaç bir imidazol türevidir ve diğer kas gevşeticilerden yapısal olarak farklıdır. Tizanidin kullanımına bağlı olarak doza bağımlı veya dozdan bağımsız bir çok yan etki bildirilmiştir. Tizanidinin yüksek dozda kullanımına bağlı zehirlenmeler nadiren görülmektedir. Literatürde yüksek dozda tizanidin alımını bildiren bir yayın vardır. Biz bu yazıda intihar amacı ile yüksek dozda tizanidin alan iki olguyu sunduk
Tizanidine poisoning (owing to two cases
Tizanidie is centrally acting muscle relaxant. The drug is an imidazole derivative structurally unrelated to other muscle relaxants. Many adverse effects, depended or undepended, to dose were reported in the literature due to tizanidin usage. Poisoning due to overdosage of tizanidine is seems uncommonly. In the literature there is only one case reporting the tizanidine overdosage. In this paper we reported two cases of tizanidine poisoning for suicidal purpose.
___
- 1. Afonso Perez E, Pego Reigosa R, Lancho Seco A, et al: Tizanidine-induced toxic hepatitis Med Clin. 1999; 112: 12, 478-479
- 2. Berry H, Hutchinson DR: A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain. J Int Med Res. 1988; 16: 2, 75-82.
- 3. Bes A, Eyssette M, Pierrot Deseilligny E: A multi centre, double blind trial of tizanidin, a new antispastic agent, in spasticity associated with hemiplegia. Curr Med Res Opin 1988; 10: 709-718.
- 4. Coward DM: Tizanidine: neuropharmacology and mechanism of action. Neurology. 1994; 44: 6-10.
- 5. de Graaf EM, Oosterveld M, Tjabbes T, et al: A case of tizanidine-induced hepatic injury. J Hepatol. 1996; 25: 5, 772-773.
- 6. Eyssette M, Rohmer F, Serratrice G, et al: Multi-centre, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerozis. Curr Med Res Opin. 1988; 10: 699-708.
- 7. http://www.drugs.com/PDR/Zanaflex Tablets. Html (Site Ziyaret Tarihi: Temmuz 2004).
- 8. Hutchinson DR: Modified release tizanidine: a review. J Int Med Res. 1989; 17: 565-573.
- 9. Kroin JS, McCarthy RJ, Penn RD, et al: Intrathecal clonidine and tizanidine in conscious dogs: comparison of analgesic and hemodynamic effects. Anesth Analg. 1996; 82: 3, 627-635.
- 10. Kroin JS, McCarthy RJ, Penn RD, et al: Continuous intrathecal clonidine and tizanidine in conscious dogs: analgesic and hemodynamic effects. Anesth Analg. 2003; 96: 3, 776-782.
- 11. Lang AE, Riley DE: Tizanidine in cranial dystonia. Clin Neuro Pharmacol 1992; 15: 142-147.
- 12. Lapierre Y, Bouchard S, Tansey C, et al: Treatment of spasticity with tizanidin in multipl sclerozis. Can J Neurol Sci. 1987; 14 (Suppl 3): 513-517.
- 13. Luciani A, Brugioni L, Serra L, et al: Sino-atrial and atrio-ventricular node dysfunction in a case of tizanidine overdose. Vet Hum Toxicol 1995; 37: 6, 556-557.
- 14. Moufarrege G, Frank E, Carstens DD: Eosinophilic exudative pleural effusion after initiation of tizanidine treatment: a case report. Pain Med 2003; 4: 1, 85-90.
- 15. Stein R, Nordal HJ, Oftedal SI, et al: The treatment of spasticity in multiple sclerozis: a double-blind clinical trial of a new antispastic drug tizanidin compared with baclofen. Acte Neurol Scand. 1987; 75: 190-194.
- 16. Thomas RJ: Excitatory amino acids in health and disease. J Am Geriatr Soc. 1995; 43: 11, 1279-1289.